[DISCLOSURE] Isu Abxis (086890) said on Aug. 12 that it has earned FDA approval in Honduras regarding Abcertin injection (imiglucerase) 200 unit, a solution used in long term alternative enzymatic treatment for patients with Gaucher’s disease.